Article

Dolutegravir Reported Adverse Drug Reactions: A Systematic Review Protocol

2021-09-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Until recently, the first-line regimen for the management of Human Immunodeficiency Virus (HIV) was Tenofovir (TDF)-Emtricitabine (FTC) and Efavirenz (EFV). However, the use of EFV has now been limited due to adverse neurosensory effects and a low genetic barrier to resistance. This regimen has been replaced by the Dolutegravir (DTG)-based regimen since DTG has...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b05c5ea3-df22-57c8-928b-cd6a6e4ab1e4
DOI: 10.21203/rs.3.rs-882616/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Dolutegravir Reported Adverse Drug Reactions: A Systematic Review ProtocolDOI 10.21203/rs.3.rs-882616/v1Read

Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study.Semantic proximity Read

Assessment of drug-induced adverse events reported for transgender population in IndiaSemantic proximity Read

Adverse drug reactions associated with the use of biological agentsSemantic proximity Read

Utility of some International Classification of Diseases 10th revision codes for detecting serious and interesting adverse drug reactions.Semantic proximity Read

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical SettingsSemantic proximity Read

Clinical outcomes of Dolutegravir treatment in people living with HIV in Brazil: Protocol for the CODE CohortSemantic proximity Read

Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.Semantic proximity Read

Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO databaseSemantic proximity Read

Antiretroviral Adverse Drug Reactions Pharmacovigilance in Harare City, Zimbabwe, 2017Semantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.Semantic proximity Read